attention deficit hyperactivity disorder


Also found in: Dictionary, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to attention deficit hyperactivity disorder: attention deficit disorder
  • noun

Synonyms for attention deficit hyperactivity disorder

a condition (mostly in boys) characterized by behavioral and learning disorders

References in periodicals archive ?
Partial List of Tables Number of Products under Development for Attention Deficit Hyperactivity Disorder (ADHD), H1 2015 13 Number of Products under Development for Attention Deficit Hyperactivity Disorder (ADHD) - Comparative Analysis, H1 2015 14 Number of Products under Development by Companies, H1 2015 16 Number of Products under Development by Companies, H1 2015 (Contd.
Hill J, Schoener E: Age-dependent decline of attention deficit hyperactivity disorder.
The study helps executives estimate Attention Deficit Hyperactivity Disorder market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks.
A snapshot of the global therapeutic scenario for Attention Deficit Hyperactivity Disorder (ADHD).
Photo: UCLA's Susan Smalley and Stanley Nelson head a research project about the genetic links that may indicate the presence of attention deficit hyperactivity disorder.
An Overview of Pipeline Products for Attention Deficit Hyperactivity Disorder (ADHD)
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, Q1 2011', provides an overview of the Attention Deficit Hyperactivity Disorder (ADHD) therapeutic pipeline.
Attention Deficit Hyperactivity Disorder (ADHD) Pipeline Review, Q4 2010, provides an overview of the Attention Deficit Hyperactivity Disorder (ADHD) therapeutic pipeline.
Figure 9: The global attention deficit hyperactivity disorder (ADHD) market split by region, 2008 26
BioBDx has created a proprietary diagnostic system for objectively measuring the core components of Attention Deficit Hyperactivity Disorder (ADHD) to aid clinicians in accurate diagnosis.
com/reports/c47133) has announced the addition of Espicom Business Intelligence's CNS Drug Discoveries: Attention Deficit Hyperactivity Disorder Chapter to their offering.
The use of transdermal drug delivery in depression and attention deficit hyperactivity disorder are poised to provide substantial growth for the industry and counteract the loss of patent protection of the largest transdermal drug, Duragesic.
Attention Deficit Hyperactivity Disorder (ADHD) is a relatively common neurodevelopmental disorder, characterized by symptoms such as restlessness and an inability to maintain concentration.
The company's focus is on AD, mild cognitive impairment (MCI), cognitive impairment associated with schizophrenia, and attention deficit hyperactivity disorder (ADHD).
s (AMEX: COR), lead AMPAKINE(R) drug, CX717, showed positive results for the treatment of adults with Attention Deficit Hyperactivity Disorder (ADHD).
Full browser ?